Context: Researchers conducted extensive investigations of hallucinogens in the 1950s and 1960s. By the early 1970s, however, political and cultural pressures forced the cessation of all projects. This investigation reexamines a potentially promising clinical application of hallucinogens in the treatment of anxiety reactive to advanced-stage cancer.
Objective: To explore the safety and efficacy of psilocybin in patients with advanced-stage cancer and reactive anxiety.
To view full document, please click here.